151 related articles for article (PubMed ID: 32564147)
21. Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Franceschi E; Minichillo S; Mura A; Tosoni A; Mascarin M; Tomasello C; Bartolini S; Brandes AA
BMC Cancer; 2020 Aug; 20(1):755. PubMed ID: 32787805
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
23. Survival and prognostic factors in adult medulloblastoma: the Salah Azaiz Institute experience.
Abidi R; Boussarsar A; Yahyaoui S; Aissaoui D; Mousli A; Kochbati L; Belaid A; Nasr C
Br J Neurosurg; 2024 Apr; 38(2):472-475. PubMed ID: 33719800
[TBL] [Abstract][Full Text] [Related]
24. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
25. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
[TBL] [Abstract][Full Text] [Related]
26. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
27. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
28. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
[TBL] [Abstract][Full Text] [Related]
29. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
30. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
Lee JW; Lim DH; Sung KW; Cho HW; Ju HY; Hyun JK; Yoo KH; Koo HH; Suh YL; Joung YS; Shin HJ
Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
[TBL] [Abstract][Full Text] [Related]
31. Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
Moots PL; O'Neill A; Londer H; Mehta M; Blumenthal DT; Barger GR; Grunnet ML; Grossman S; Gilbert MR; Schiff D
Am J Clin Oncol; 2018 Jun; 41(6):588-594. PubMed ID: 27635620
[TBL] [Abstract][Full Text] [Related]
32. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome and prognostic factors of medulloblastoma.
Wang KC; Lee JI; Cho BK; Kim IH; Kim JY; Shin HY; Ahn HS; Han DH
J Korean Med Sci; 1994 Feb; 9(1):64-73. PubMed ID: 8068221
[TBL] [Abstract][Full Text] [Related]
34. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
35. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P
Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242
[TBL] [Abstract][Full Text] [Related]
36. Decade-long disease, secondary malignancy, and brainstem injury outcomes in pediatric and young adult medulloblastoma patients treated with proton radiotherapy.
Baliga S; Gallotto S; Bajaj B; Lewy J; Weyman E; Lawell MP; Yeap BY; Ebb DE; Huang M; Caruso P; Perry A; Jones RM; MacDonald SM; Tarbell NJ; Yock TI
Neuro Oncol; 2022 Jun; 24(6):1010-1019. PubMed ID: 34788463
[TBL] [Abstract][Full Text] [Related]
37. Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome.
Grabenbauer GG; Beck JD; Erhardt J; Seegenschmiedt MH; Seyer H; Thierauf P; Sauer R
Am J Clin Oncol; 1996 Feb; 19(1):73-7. PubMed ID: 8554041
[TBL] [Abstract][Full Text] [Related]
38. Modern treatment strategies in medulloblastoma.
Kühl J
Childs Nerv Syst; 1998; 14(1-2):2-5. PubMed ID: 9548331
[TBL] [Abstract][Full Text] [Related]
39. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
[TBL] [Abstract][Full Text] [Related]
40. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
